articleThe LancetJun 18, 2019Closed access

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

AWAnders WidmarkAGAdalsteinn GunnlaugssonLBL. BeckmanCTCamilla Thellenberg‐KarlssonMHMorten Høyer

Umeå University · Lund University · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

869
total citations
FWCI
74.31
Percentile
100%
References
28
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • Medicine
  • Prostate cancer
  • Prostate
  • Radiation therapy
  • Randomized controlled trial
  • Oncology
  • Cancer
  • Internal medicine
No related works found for this paper.

Funding